Akebia Therapeutics
AKBA
#6743
Rank
NZ$0.89 B
Marketcap
$3.41
Share price
1.31%
Change (1 day)
24.86%
Change (1 year)

EPS for Akebia Therapeutics (AKBA)

EPS in 2023 (TTM): -$1.07

According to Akebia Therapeutics's latest financial reports the company's current EPS (TTM) is -$1.13. In 2022 the company made an earnings per share (EPS) of -$0.90 an increase over its 2021 EPS that were of -$3.00.

EPS history for Akebia Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.0719.09%
2022-$0.90-70%
2021-$3.00-38.63%
2020-$4.8817.37%
2019-$4.162.79%
2018-$4.0531.2%
2017-$3.08-51.39%
2016-$6.3557.89%
2015-$4.02-94.83%
2014-$77.75589.75%
2013-$11.27

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$24.94-2,310.94%๐Ÿ‡บ๐Ÿ‡ธ USA
$6.59-684.38%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
$24.83-2,300.83%๐Ÿ‡บ๐Ÿ‡ธ USA
-$2.87 154.69%๐Ÿ‡บ๐Ÿ‡ธ USA